Actively Recruiting
Study of Multiprofen-CC Cream to Ease Pain and Improve Function in Adults with Hand Osteoarthritis A Phase 3 Randomized Crossover Trial Comparing Active Cream to Placebo
Led by St. Joseph's Healthcare Hamilton · Updated on 2026-05-04
42
Participants Needed
1
Research Sites
30 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating whether applying 1 gram of Multiprofen-CC cream to the hands three times daily for 4 weeks can reduce pain in adults with hand osteoarthritis, compared to a placebo cream without active medicine. This Phase 3 clinical trial also examines how this treatment affects hand function, opioid use, and patients overall improvement while monitoring any side effects. Participants will use both the active Multiprofen-CC cream and a placebo cream in a random order, applying each 1 gram dose three times daily for 2 weeks. The cream contains ketoprofen, baclofen, amitriptyline, and lidocaine, while the placebo cream contains no medicinal ingredients. The study includes a crossover design where participants switch between treatments. During the study, participants will attend visits before starting, after 2 weeks, and again after 6 weeks. They will report symptoms and side effects throughout. Researchers will measure pain intensity at baseline, weeks 2, 4, and 6, along with hand function and patient-reported improvement. Safety is monitored by tracking adverse events over approximately 6 weeks.
CONDITIONS
Brief Title
Multiprofen-CC to Reduce Pain in Hand Arthritis
Research Team
B
Breanne Flood, MSc
K
Kim Irish, BSW
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here